Cancer Research Annual Meeting 2010 Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
[Cancer Research 48, 6739-6744, December 1, 1988]
© 1988 American Association for Cancer Research
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marsman, D. S.
Right arrow Articles by Popp, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marsman, D. S.
Right arrow Articles by Popp, J. A.

Relationship of Hepatic Peroxisome Proliferation and Replicative DNA Synthesis to the Hepatocarcinogenicity of the Peroxisome Proliferators Di(2-ethylhexyl)phthalate and [4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic Acid (Wy-14,643) in Rats

Daniel S. Marsman1, Russell C. Cattley2, James G. Conway3 and James A. Popp

Chemical Industry Institute of Toxicology, Research Triangle Park, North Carolina 27709

The mechanism of hepatocarcinogenesis caused by peroxisome proliferators (PP) is poorly understood, making it difficult to predict the carcinogenicity of PP to rodents or other species. It has been suggested that the carcinogenic potential of individual PP in rodents is correlated with the degree of PP-induced hepatic peroxisome proliferation. To evaluate this possible correlation, di(2-ethylhexyl)phthalate (DEHP) at 1.2% and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) at 0.1% were fed to male F-344 rats for up to 365 days and hepatocytic peroxisome proliferation and DNA replication were measured. All rats fed Wy-14,643 for 365 days had numerous grossly visible nodules in comparison to none in the livers of DEHP-fed or control rats. Despite this difference in the induction of tumors, both DEHP and Wy-14,643 increased the peroxisomal volume density 4- to 6-fold from 8 to 365 days of treatment. Peroxisomal ß-oxidation enzyme activities were increased 8-fold by both DEHP and Wy-14,643 after 18 days. At later time points (77 to 365 days), these enzyme activities were about 25% higher in livers of Wy-14,643- than DEHP-fed rats. DEHP or Wy-14,643 increased absolute liver weights 50 to 75% above controls after 18 to 365 days of feeding. Labeling of hepatocyte nuclei with a single injection of tritiated thymidine revealed a rapid burst in replicative DNA synthesis in both DEHP and Wy-14,643-fed rats, with a return to control levels by 4 days. Additional rats were implanted with 7-day osmotic pumps containing tritiated thymidine. With this more extended method of labeling a 5- to 10-fold increase in replicative DNA synthesis was observed in rats receiving Wy-14,643 for 39 to 365 days as compared to DEHP-fed rats or controls. In conclusion, when performed under conditions similar to the tumorigenicity studies, the degree of peroxisome proliferation correlated poorly with the relative hepatocarcinogenicity of DEHP and Wy-14,643. However, a strong correlation was observed between the relative hepatocarcinogenicity of DEHP and Wy-14,643 and the ability to induce a persistent increase in replicative DNA synthesis. These data emphasize the possible importance of cell replication in the mechanism of PP-induced hepatocarcinogenesis.

1 To whom requests for reprints should be addressed, at CIIT, P.O. Box 12137, Research Triangle Park, NC 27709.

2 Present address: College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27606. R.C.C. was supported in part by grant CA 07945 from the Public Health Service, US Department of Health and Human Services.

3 Present address: Glaxo Inc., 5 Moore Drive, Research Triangle Park, NC 27709.

Received 2/23/88. Revised 7/12/88. Accepted 9/ 1/88.




This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
M. A. Gyamfi and Y.-J. Y. Wan
Mechanisms of Resistance of Hepatocyte Retinoid X Receptor {alpha}-Null Mice to WY-14,643-induced Hepatocyte Proliferation and Cholestasis
J. Biol. Chem., April 3, 2009; 284(14): 9321 - 9330.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
M. Kawai, M. Jin, J. Nishimura, Y. Dewa, Y. Saegusa, S. Matsumoto, E. Taniai, M. Shibutani, and K. Mitsumori
Hepatocarcinogenic Susceptibility of Fenofibrate and Its Possible Mechanism of Carcinogenicity in a Two-Stage Hepatocarcinogenesis Model of rasH2 Mice
Toxicol Pathol, December 1, 2008; 36(7): 950 - 957.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
A. Al Kholaifi, A. Amer, B. Jeffery, T. J. B. Gray, R. A. Roberts, and D. R. Bell
Species-Specific Kinetics and Zonation of Hepatic DNA Synthesis Induced by Ligands of PPAR{alpha}
Toxicol. Sci., July 1, 2008; 104(1): 74 - 85.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
T. Makino, K. Ishikawa, I. Igarashi, T. Yamoto, S. Manabe, and H. Nakayama
Relationship between GST Yp Induction and Hepatocyte Proliferation in Rats Treated with Phase II Drug Metabolizing Enzyme Inducers
Toxicol Pathol, April 1, 2008; 36(3): 420 - 427.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
C. G. Woods, A. M. Burns, B. U. Bradford, P. K. Ross, O. Kosyk, J. A. Swenberg, M. L. Cunningham, and I. Rusyn
WY-14,643 Induced Cell Proliferation and Oxidative Stress in Mouse Liver are Independent of NADPH Oxidase
Toxicol. Sci., August 1, 2007; 98(2): 366 - 374.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
C. G. Woods, J. P. Vanden Heuvel, and I. Rusyn
Genomic Profiling in Nuclear Receptor-Mediated Toxicity
Toxicol Pathol, June 1, 2007; 35(4): 474 - 494.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
Q. Yang, S. Ito, and F. J. Gonzalez
Hepatocyte-restricted constitutive activation of PPAR{alpha} induces hepatoproliferation but not hepatocarcinogenesis
Carcinogenesis, June 1, 2007; 28(6): 1171 - 1177.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
R. A. Roberts, P. E. Ganey, C. Ju, L. M. Kamendulis, I. Rusyn, and J. E. Klaunig
Role of the Kupffer Cell in Mediating Hepatic Toxicity and Carcinogenesis
Toxicol. Sci., March 1, 2007; 96(1): 2 - 15.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
A. Tedgui and Z. Mallat
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Physiol Rev, April 1, 2006; 86(2): 515 - 581.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
H. P. Glauert, A. Eyigor, J. C. Tharappel, S. Cooper, E. Y. Lee, and B. T. Spear
Inhibition of Hepatocarcinogenesis by the Deletion of the p50 Subunit of NF-{kappa}B in Mice Administered the Peroxisome Proliferator Wy-14,643
Toxicol. Sci., April 1, 2006; 90(2): 331 - 336.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
O. S. Gardner, B. J. Dewar, and L. M. Graves
Activation of Mitogen-Activated Protein Kinases by Peroxisome Proliferator-Activated Receptor Ligands: An Example of Nongenomic Signaling
Mol. Pharmacol., October 1, 2005; 68(4): 933 - 941.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
B. Knight, B. B. Yeap, G. C. Yeoh, and J. K. Olynyk
Inhibition of adult liver progenitor (oval) cell growth and viability by an agonist of the peroxisome proliferator activated receptor (PPAR) family member {gamma}, but not {alpha} or {delta}
Carcinogenesis, October 1, 2005; 26(10): 1782 - 1792.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
D. E. Amacher, R. Adler, A. Herath, and R. R. Townsend
Use of Proteomic Methods to Identify Serum Biomarkers Associated with Rat Liver Toxicity or Hypertrophy
Clin. Chem., October 1, 2005; 51(10): 1796 - 1803.
[Abstract] [Full Text] [PDF]

Home page
 International Journal of ToxicologyHome page
C. E. Torrey, H. G. Wall, J. A. Campbell, P. Kwanyuen, D. J. Hoivik, R. T. Miller, J. S. Allen, M. J. Jayo, K. Selinger, P. M. Savina, et al.
Evaluation of the Carcinogenic Potential of Clofibrate in FVB/Tg.AC Mouse After Oral Administration--Part I
International Journal of Toxicology, September 1, 2005; 24(5): 313 - 325.
[Abstract] [Full Text] [PDF]

Home page
 International Journal of ToxicologyHome page
C. E. Torrey, H. G. Wall, J. A. Campbell, P. Kwanyuen, D. J. Hoivik, R. T. Miller, J. S. Allen, M. J. Jayo, K. Selinger, and M. J. Santostefano
Evaluation of the Carcinogenic Potential of Clofibrate in the FVB/Tg.AC Mouse After Dermal Application--Part II
International Journal of Toxicology, September 1, 2005; 24(5): 327 - 339.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
G.M. Ledda-Columbano, M. Pibiri, F. Molotzu, C. Cossu, L. Sanna, G. Simbula, A. Perra, and A. Columbano
Induction of hepatocyte proliferation by retinoic acid
Carcinogenesis, November 1, 2004; 25(11): 2061 - 2066.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
D. J. Hoivik, C. W. Qualls Jr, R. C. Mirabile, N. F. Cariello, C. L. Kimbrough, H. M. Colton, S. P. Anderson, M. J. Santostefano, R. J. O. Morgan, R. R. Dahl, et al.
Fibrates induce hepatic peroxisome and mitochondrial proliferation without overt evidence of cellular proliferation and oxidative stress in cynomolgus monkeys
Carcinogenesis, September 1, 2004; 25(9): 1757 - 1769.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
R. L. Brent
Utilization of Animal Studies to Determine the Effects and Human Risks of Environmental Toxicants (Drugs, Chemicals, and Physical Agents)
Pediatrics, April 1, 2004; 113(4/S1): 984 - 995.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
R. C. Cattley
Peroxisome Proliferators and Receptor-Mediated Hepatic Carcinogenesis
Toxicol Pathol, February 1, 2004; 32(2_suppl): 6 - 11.
[Abstract] [PDF]

Home page
 Toxicol SciHome page
J. C. Tharappel, A. Nalca, A. B. Owens, L. Ghabrial, E. C. Konz, H. P. Glauert, and B. T. Spear
Cell Proliferation and Apoptosis Are Altered in Mice Deficient in the NF-{kappa}B p50 Subunit after Treatment with the Peroxisome Proliferator Ciprofibrate
Toxicol. Sci., October 1, 2003; 75(2): 300 - 308.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
F. Yadetie, A. Laegreid, I. Bakke, W. Kusnierczyk, J. Komorowski, H. L. Waldum, and A. K. Sandvik
Liver gene expression in rats in response to the peroxisome proliferator-activated receptor-{alpha} agonist ciprofibrate
Physiol Genomics, September 29, 2003; 15(1): 9 - 19.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
O. Moennikes, S. Stahl, P. Bannasch, A. Buchmann, and M. Schwarz
WY-14,643-mediated promotion of hepatocarcinogenesis in connexin32-wild-type and connexin32-null mice
Carcinogenesis, September 1, 2003; 24(9): 1561 - 1565.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Fischer, M. You, M. Matsumoto, and D. W. Crabb
Peroxisome Proliferator-activated Receptor {alpha} (PPAR{alpha}) Agonist Treatment Reverses PPAR{alpha} Dysfunction and Abnormalities in Hepatic Lipid Metabolism in Ethanol-fed Mice
J. Biol. Chem., July 18, 2003; 278(30): 27997 - 28004.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
J. A. Kramer, E. A.G. Blomme, R. T. Bunch, J. C. Davila, C. J. Jackson, P. F. Jones, K. L. Kolaja, and S. W. Curtiss
Transcription Profiling Distinguishes Dose-Dependent Effects in the Livers of Rats Treated with Clofibrate
Toxicol Pathol, June 1, 2003; 31(4): 417 - 431.
[Abstract] [PDF]

Home page
 CarcinogenesisHome page
G. M. Ledda-Columbano, M. Pibiri, D. Concas, F. Molotzu, G. Simbula, C. Cossu, and A. Columbano
Sex difference in the proliferative response of mouse hepatocytes to treatment with the CAR ligand, TCPOBOP
Carcinogenesis, June 1, 2003; 24(6): 1059 - 1065.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. D. Wheeler, O. M. Smutney, J. F. Check, I. Rusyn, R. Schulte-Hermann, and R. G. Thurman
Impaired Ras membrane association and activation in PPARalpha knockout mice after partial hepatectomy
Am J Physiol Gastrointest Liver Physiol, February 1, 2003; 284(2): G302 - G312.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
M. L. O'Brien, M. L. Cunningham, B. T. Spear, and H. P. Glauert
Peroxisome Proliferators Do Not Activate the Transcription Factors AP-1, Early Growth Response-1, or Heat Shock Factors 1 and 2 in Rats or Hamsters
Toxicol. Sci., September 1, 2002; 69(1): 139 - 148.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
R. Ge, W. Wang, P. M. Kramer, S. Yang, L. Tao, and M. A. Pereira
Wy-14,643-Induced Hypomethylation of the c-myc Gene in Mouse Liver
Toxicol. Sci., July 1, 2001; 62(1): 28 - 35.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
A. Kiss, R. Ortiz-Aguayo, R. Sharp, G. Merlino, S. S. Thorgeirsson, F. J. Gonzalez, and J. M. Peters
Evidence that reduction of hepatocyte growth factor (HGF) is not required for peroxisome proliferator-induced hepatocyte proliferation
Carcinogenesis, June 1, 2001; 22(6): 975 - 979.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
I. Rusyn, M. B. Kadiiska, A. Dikalova, H. Kono, M. Yin, K. Tsuchiya, R. P. Mason, J. M. Peters, F. J. Gonzalez, B. H. Segal, et al.
Phthalates Rapidly Increase Production of Reactive Oxygen Species in Vivo: Role of Kupffer Cells
Mol. Pharmacol., April 1, 2001; 59(4): 744 - 750.
[Abstract] [Full Text]

Home page
 Toxicol SciHome page
L. B. Biegel, M. E. Hurtt, S. R. Frame, J. C. O'Connor, and J. C. Cook
Mechanisms of Extrahepatic Tumor Induction by Peroxisome Proliferators in Male CD Rats
Toxicol. Sci., March 1, 2001; 60(1): 44 - 55.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
W. Parzefall, W. Berger, E. Kainzbauer, O. Teufelhofer, R. Schulte-Hermann, and R. G. Thurman
Peroxisome proliferators do not increase DNA synthesis in purified rat hepatocytes
Carcinogenesis, March 1, 2001; 22(3): 519 - 523.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
I. Rusyn, S. Yamashina, B. H. Segal, R. Schoonhoven, S. M. Holland, R. C. Cattley, J. A. Swenberg, and R. G. Thurman
Oxidants from Nicotinamide Adenine Dinucleotide Phosphate Oxidase Are Involved in Triggering Cell Proliferation in the Liver Due to Peroxisome Proliferators
Cancer Res., September 1, 2000; 60(17): 4798 - 4803.
[Abstract] [Full Text]

Home page
 Toxicol SciHome page
J. S. Isenberg, L. M. Kamendulis, J. H. Smith, D. C. Ackley, G. Pugh Jr., A. W. Lington, and J. E. Klaunig
Effects of Di-2-Ethylhexyl Phthalate (DEHP) on Gap-Junctional Intercellular Communication (GJIC), DNA Synthesis, and Peroxisomal Beta Oxidation (PBOX) in Rat, Mouse, and Hamster Liver
Toxicol. Sci., July 1, 2000; 56(1): 73 - 85.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
J. M. Peters, I. Rusyn, M. L. Rose, F. J. Gonzalez, and R. G. Thurman
Peroxisome proliferator-activated receptor {alpha} is restricted to hepatic parenchymal cells, not Kupffer cells: implications for the mechanism of action of peroxisome proliferators in hepatocarcinogenesis
Carcinogenesis, April 1, 2000; 21(4): 823 - 826.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
I. G. Shabalina, T. Panaretakis, A. Bergstrand, and J. W. Depierre
Effects of the rodent peroxisome proliferator and hepatocarcinogen, perfluorooctanoic acid, on apoptosis in human hepatoma HepG2 cells
Carcinogenesis, December 1, 1999; 20(12): 2237 - 2246.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
M. L. Rose, R. C. Cattley, C. Dunn, V. Wong, X. Li, and R. G. Thurman
Dietary glycine prevents the development of liver tumors caused by the peroxisome proliferator WY-14,643
Carcinogenesis, November 1, 1999; 20(11): 2075 - 2081.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
I. Rusyn, C. A. Bradham, L. Cohn, R. Schoonhoven, J. A. Swenberg, D. A. Brenner, and R. G. Thurman
Corn oil rapidly activates nuclear factor-{kappa}B in hepatic Kupffer cells by oxidant-dependent mechanisms
Carcinogenesis, November 1, 1999; 20(11): 2095 - 2100.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol Ind HealthHome page
Regulations and Advisories
Toxicology and Industrial Health, September 1, 1999; 15(8): 718 - 742.
[PDF]

Home page
 Toxicol PatholHome page
A. R. Soames, S. Cliffe, I. Pate, and J. R. Foster
Quantitative Analysis of the Lobular Distribution of S-Phase in Rat Liver Following Dietary Administration of Di(2-ethylhexyl)phthalate
Toxicol Pathol, July 1, 1999; 27(4): 436 - 440.
[Abstract] [PDF]

Home page
 CarcinogenesisHome page
M. L. Rose, J. Madren, H. Bunzendahl, and R. G. Thurman
Dietary glycine inhibits the growth of B16 melanoma tumors in mice
Carcinogenesis, May 1, 1999; 20(5): 793 - 798.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
M. L. Rose, C. A. Rivera, B. U. Bradford, L. M. Graves, R. C. Cattley, R. Schoonhoven, J. A. Swenberg, and R. G. Thurman
Kupffer cell oxidant production is central to the mechanism of peroxisome proliferators
Carcinogenesis, January 1, 1999; 20(1): 27 - 33.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Motojima, P. Passilly, J. M. Peters, F. J. Gonzalez, and N. Latruffe
Expression of Putative Fatty Acid Transporter Genes Are Regulated by Peroxisome Proliferator-activated Receptor alpha  and gamma  Activators in a Tissue- and Inducer-specific Manner
J. Biol. Chem., July 3, 1998; 273(27): 16710 - 16714.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. L. Rokos and B. J. Ledwith
Peroxisome Proliferators Activate Extracellular Signal-regulated Kinases in Immortalized Mouse Liver Cells
J. Biol. Chem., May 16, 1997; 272(20): 13452 - 13457.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Miyamoto, A. Kaneko, T. Kakizawa, H. Yajima, K. Kamijo, R. Sekine, K. Hiramatsu, Y. Nishii, T. Hashimoto, and K. Hashizume
Inhibition of Peroxisome Proliferator Signaling Pathways by Thyroid Hormone Receptor. COMPETITIVE BINDING TO THE RESPONSE ELEMENT
J. Biol. Chem., March 21, 1997; 272(12): 7752 - 7758.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
N. D. Lalwani, L. A. Dethloff, J. R. Haskins, D. G. Robertson, and F. A. De La Iglesia
Increased Nuclear Ploidy, Not Cell Proliferation, Is Sustained in the Peroxisome Proliferator-Treated Rat Liver
Toxicol Pathol, March 1, 1997; 25(2): 165 - 176.
[Abstract] [PDF]

Home page
 J. Biol. Chem.Home page
B. J. Ledwith, C. J. Pauley, L. K. Wagner, C. L. Rokos, D. W. Alberts, and S. Manam
Induction of Cyclooxygenase-2 Expression by Peroxisome Proliferators and Non-tetradecanoylphorbol 12,13-Myristate-type Tumor Promoters in Immortalized Mouse Liver Cells
J. Biol. Chem., February 7, 1997; 272(6): 3707 - 3714.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
X. Ma, D. A. Stoffregen, G. D. Wheelock, J. A. Rininger, and J. G. Babish
Discordant Hepatic Expression of the Cell Division Control Enzyme p34cdc2 Kinase, Proliferating Cell Nuclear Antigen, p53 Tumor Suppressor Protein, and p21Waf1 Cyclin-Dependent Kinase Inhibitory Protein after WY14,643 ([4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthio]Acetic Acid) Dosing to Rats
Mol. Pharmacol., January 1, 1997; 51(1): 69 - 78.
[Abstract] [Full Text]

Home page
 Hum Exp ToxicolHome page
J. Ashby, A. Brady, C.R. Elcombe, B.M. Elliott, J. Ishmael, J. Odum, J.D. Tugwood, S. Kettle, and I.F.H. Purchase
Mechanistically-based Human Hazard Assessment of Peroxisome Proliferator-induced Hepatocarcinogenesis
Human and Experimental Toxicology, January 1, 1994; 13(2_suppl): S1 - S117.
[PDF]

Home page
 J. Cell Sci.Home page
A. Bayly, N. French, C Dive, and R. Roberts
Non-genotoxic hepatocarcinogenesis in vitro: the FaO hepatoma line responds to peroxisome proliferators and retains the ability to undergo apoptosis
J. Cell Sci., January 2, 1993; 104(2): 307 - 315.
[Abstract] [PDF]

Home page
 Toxicol PatholHome page
A. M. Bendele, J. F. Hulman, S. White, C. Brodhecker, and R. A. Bendele
Hepatocellular Proliferation in Ibuprofen-Treated Mice
Toxicol Pathol, January 1, 1993; 21(1): 15 - 20.
[Abstract] [PDF]

Home page
 International Journal of ToxicologyHome page
I. C. Munro, G. L. Carlo, J. C. Orr, K. G. Sund, R. M. Wilson, E. Kennepohl, B. S. Lynch, and M. Jablinske
A Comprehensive, Integrated Review and Evaluation of the Scientific Evidence Relating to the Safety of the Herbicide 2,4-D
International Journal of Toxicology, September 1, 1992; 11(5): 559 - 664.
[Abstract] [PDF]

Home page
 Toxicol PatholHome page
B. I. Ghanayem, H. B. Matthews, and R. R. Maronpot
Sustainability of Forestomach Hyperplasia in Rats Treated with Ethyl Acrylate for 13 Weeks and Regression after Cessation of Dosing
Toxicol Pathol, April 1, 1991; 19(3): 273 - 279.
[Abstract] [PDF]

Home page
 Hum Exp ToxicolHome page
S. Green
Receptor-Mediated Non-Genotoxic Carcinogenesis: New Models for Risk Assessment?
Human and Experimental Toxicology, January 1, 1991; 10(6): 390 - 395.
[PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.